Over-the-counter β2-agonist purchase versus script: A cross-sectional study
Authors:
- Jo A. DouglassJDJo A. Douglass
- Dianne P. GoemanDGDianne P. Goeman
- Edwina A. McCarthyEMEdwina A. McCarthy
- Susan M. SawyerSSSusan M. Sawyer
- Rosalie A. AroniRARosalie A. Aroni
- Kay StewartKSKay Stewart
- Michael J. AbramsonMichael J. Abramson
- 1 February 2012
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 106 (2) , 223-229
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Asthma control in Europe: A real-world evaluation based on an international population-based studyJournal of Allergy and Clinical Immunology, 2007
- Asthma management and outcomes in Australia: A nation‐wide telephone interview survey*Respirology, 2007
- β agonists: What is the evidence that their use increases the risk of asthma morbidity and mortality?Journal of Allergy and Clinical Immunology, 1999
- Asthma management and mode of acquisition of inhaled bronchodilatorsAustralian and New Zealand Journal of Medicine, 1995
- Standardization of Spirometry, 1994 Update. American Thoracic SocietyAmerican Journal of Respiratory and Critical Care Medicine, 1995
- The European Community Respiratory Health SurveyEuropean Respiratory Journal, 1994
- Association between availability of non-prescription beta 2 agonist inhalers and undertreatment of asthma.BMJ, 1993
- Lung volumes and forced ventilatory flowsEuropean Respiratory Journal, 1993
- Asthma mortality and inhaled beta agonist therapyAustralian and New Zealand Journal of Medicine, 1991
- The use of non‐prescription salbutamol inhalers by asthmatic patients in the Hunter Valley, New South WalesMedical Journal of Australia, 1989